Ro 22-0654
Ro 22-0654 is a potent lipid synthesis inhibitor. Ro 22-0654 inhibits hepatic fatty acid synthesis and has antiobesity effects[1].
Product Specifications
UNSPSC
12352005
Hazard Statement
H315-H319-H320
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ro-22-0654.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CSC(CC)=C1N)OC
Molecular Formula
C8H11NO2S
Molecular Weight
185.24
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
[1]J Triscari, et al. Antiobesity effects of a novel lipid synthesis inhibitor (Ro 22-0654) . Life Sci. 1984 Jun 18;34 (25) :2433-42.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-105900/Ro-22-0654-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-105900/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[81741-99-3]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Rabbit Monoclonal Carbonic Anhydrase IX/CA9 Antibody (CA9/2993R) [Alexa Fluor 647]
Factor XIIIa (Coagulation Factor XIIIA Chain) (F13A1/1448), CF405S conjugate, 0.1mg/mL